REQUEST A DEMO
Total
USD $0.00
Search more companies

Quimera Vet-Labs S.A.S. (Ecuador)

Main Activities: Medical and Diagnostic Laboratories
Full name: Quimera Vet-Labs S.A.S. Profile Updated: September 08, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Quimera Vet-Labs S.A.S. is a company based in Ecuador, with its head office in Quito. The enterprise currently operates in the Medical and Diagnostic Laboratories sector. It was first established on May 19, 2023. The total number of employees is currently 4 (2024). From the latest financial highlights, Quimera Vet-Labs S.A.S. reported a net sales revenue increase of 272.36% in 2025. Its total assets grew by 8.33% over the same period. In, 2025, the company’s net profit margin decreased by 14.71%.

Headquarters
Av. de los Shyris, N44-109
Quito; Pichincha;

Contact Details: Purchase the Quimera Vet-Labs S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Quimera Vet-Labs S.A.S. report to view the information.
Registered Capital:
Purchase the Quimera Vet-Labs S.A.S. report to view the information.
Financial Auditors:
Purchase the Quimera Vet-Labs S.A.S. report to view the information.
Incorporation Date:
May 19, 2023
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Quimera Vet-Labs S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
272.36%
Total Operating Revenue
272.36%
Operating Profit
-57.73%
EBITDA
-57.73%
Net Profit/Loss for the Period
-57.73%
Total Assets
8.33%
Total Equity
8.33%
Operating Profit Margin
-14.71%
Net Profit Margin
-14.71%
Return on Equity (ROE)
-12.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?